GeneTether Therapeutics Inc. (GTTX.CN)

0.0450 0.0000 (0.00%) At close: 11:03AM EDT

GeneTether Therapeutics Inc.

301 – 1665 Ellis Street
Kelowna, BC V1Y 2B3
Canada
514-796-2640
https://genetether.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Roland Boivin	Director & CEO	179.32k	N/A	1967
Dr. William James Garner M.D., M.P.H., MPH	Co-Founder & Executive Director	28.28k	N/A	1966
Ms. Jean M. Jen C.A., CPA	CFO & Corporate Secretary	127.44k	N/A	1988
Dr. R. Geoffrey Sargent Ph.D.	Co-Founder & Chief Scientific Officer	N/A	N/A	1955

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

GeneTether Therapeutics Inc., a genetic medicines company, focuses on developing gene editing therapies to enhance the efficiency of genome editing technologies. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada.

Corporate Governance

GeneTether Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.